Cargando…
Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection
INTRODUCTION: Small intestinal bacterial overgrowth (SIBO) may coexist with Helicobacter pylori infection, which can be the cause of chronic gastrointestinal complaints. AIM: Evaluation of the therapeutic efficacy of amoxicillin and rifaximin in the treatment of these diseases. MATERIAL AND METHODS:...
Autores principales: | Konrad, Paulina, Chojnacki, Jan, Gąsiorowska, Anita, Rudnicki, Cezary, Kaczka, Aleksandra, Chojnacki, Cezary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173078/ https://www.ncbi.nlm.nih.gov/pubmed/30302165 http://dx.doi.org/10.5114/pg.2018.74228 |
Ejemplares similares
-
Serotonin Pathway of Tryptophan Metabolism in Small Intestinal Bacterial Overgrowth—A Pilot Study with Patients Diagnosed with Lactulose Hydrogen Breath Test and Treated with Rifaximin
por: Chojnacki, Cezary, et al.
Publicado: (2021) -
Antimicrobial treatment improves tryptophan metabolism and mood of patients with small intestinal bacterial overgrowth
por: Chojnacki, Cezary, et al.
Publicado: (2022) -
Altered Tryptophan Metabolism on the Kynurenine Pathway in Depressive Patients with Small Intestinal Bacterial Overgrowth
por: Chojnacki, Cezary, et al.
Publicado: (2022) -
The value of melatonin supplementation in postmenopausal women with Helicobacter pylori-associated dyspepsia
por: Chojnacki, Cezary, et al.
Publicado: (2020) -
Expression of tryptophan hydroxylase in gastric mucosa in symptomatic and asymptomatic Helicobacter pylori infection
por: Chojnacki, Cezary, et al.
Publicado: (2018)